| E-Y0001692 |
EP |
|
Imatinib for system suitability |
|
5 mg |
1264 |
28 |
| E-Y0001691 |
EP |
|
Imatinib mesilate |
|
120 mg |
1264 |
28 |
| E-Y0001689 |
EP |
【免疫球蛋白（抗A，抗B |
Immunoglobulin (anti-A, anti-B antibodies test) Negative control |
|
50 mg |
1484.59 |
42 |
| E-Y0001688 |
EP |
【免疫球蛋白（抗A，抗B |
Immunoglobulin (anti-A, anti-B antibodies test) Positive control |
|
46 mg |
1484.59 |
42 |
| E-Y0001687 |
EP |
【水飛薊干浸膏HRS（ |
Milk thistle dry extract HRS |
|
120 mg |
1484.59 |
42 |
| E-Y0001686 |
EP |
【乙硫異煙胺系統(tǒng)適 |
Ethionamide for system suitability |
|
10 mg |
1264 |
28 |
| E-Y0001685 |
EP |
【氨基葡萄糖硫酸鉀 |
Glucosamine sulfate potassium chloride |
|
10 mg |
1264 |
28 |
| E-Y0001684 |
EP |
【高相對分子質(zhì)量聚 |
High-molecular-mass macrogol CRS |
|
10 mg |
1264 |
28 |
| E-Y0001683 |
EP |
【司他夫定雜質(zhì)I（訂 |
Stavudine impurity I |
|
5 mg |
1264 |
28 |
| E-Y0001682 |
EP |
【吉西他濱雜質(zhì)C（訂 |
Gemcitabine impurity C |
|
5 mg |
1264 |
28 |
| E-Y0001681 |
EP |
【丙胺卡因峰值鑒別 |
Prilocaine for peak identification |
|
20 mg |
1264 |
28 |
| E-Y0001680 |
EP |
【克林霉素磷酸酯系 |
Clindamycin phosphate for system suitability |
|
10 mg |
1264 |
28 |
| E-Y0001679 |
EP |
【磺胺二甲氧嘧啶峰 |
Sulfadimethoxine for peak identification |
|
10 mg |
1264 |
28 |
| E-Y0001678 |
EP |
【阿侖膦酸鈉系統(tǒng)適 |
Sodium alendronate for system suitability |
|
5 mg |
1264 |
28 |
| E-Y0001677 |
EP |
【磺胺二甲氧嘧啶（訂 |
Sulfadimethoxine |
|
60 mg |
1264 |
28 |
粵公網(wǎng)安備 44010302000979號
